Journal
ONCOLOGY AND THERAPY
Volume 8, Issue 1, Pages 1-11Publisher
SPRINGER
DOI: 10.1007/s40487-019-00105-0
Keywords
Aromatase inhibitors; Breast cancer; Endocrine therapy; Histology; Immunotherapy; Invasive lobular carcinoma; Molecular biology; Surgical management; Tamoxifen; Targeted therapy
Categories
Ask authors/readers for more resources
Invasive lobular carcinoma comprises 10-15% of all breast cancers and is increasingly recognised as a distinct and understudied disease compared with the predominant histological subtype, invasive ductal carcinoma. Hallmarks of invasive lobular carcinoma include E-cadherin loss, leading to discohesive morphology with cells proliferating in single-file strands and oestrogen receptor positivity, with favourable response to endocrine therapy. This review summarises the distinct histological and molecular features of invasive lobular carcinoma with focus on diagnostic challenges and the impact on surgical management and medical therapy. Emphasis is placed on recent advances in our understanding of the unique molecular biology of lobular breast cancer and how this is optimising our therapy approach in the clinic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available